QBE – Morgans rates the stock as Add

The FY20 results for QBE Insurance Group had largely been pre-released and Morgans states that many of the factors leading to a disappointing profit (NPAT) loss of -US$712m obscured improving underlying profitability trends driven by the ‘Brilliant Basics’ program and an increasingly favourable global pricing environment.

Read More

HLS – Morgans rates the stock as Hold

Healius provided a trading update, expecting to report FY20 underlying earnings (EBIT) of $102m-$104m and underlying profit (NPAT) of $54m-56m. Morgans states that covid-19 impacts were seen across all segments, with Imaging and Day Hospitals/IVF faring the worst, while Pathology did better as covid-19 testing helped buffer declines across base testing.

Read More